Alnylam Pharmaceuticals

+$4.64 (+2.69%) Today
-$0.93 (-0.53%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ALNY and other stocks, options, and ETFs commission-free!

About ALNY

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. The firm's products include ONPATTRO, GIVLAARI, and OXLUMO.

CEO
John M. Maraganore
Employees
1,453
Headquarters
Cambridge, Massachusetts
Founded
2002

ALNY Key Statistics

Market Cap
20.79B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
841.77K
High Today
$177.53
Low Today
$170.01
Open Price
$171.08
Volume
1.52M
52 Week High
$178.41
52 Week Low
$119.29

ALNY Earnings

-$2.23
-$1.49
-$0.74
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure